Request For Information (RFI) (2) for device & maintenance services for medical point-of-care molecular disease analyzer
SAM.GOV Due: May 28, 2025 at 07:00 PM UTC
In-Active Sources Sought Source Url

Summary

The United States Coast Guard (USCG) is seeking information through a Request For Information (RFI) regarding device and maintenance services for medical point-of-care molecular disease analyzers. This RFI aims to explore potential alternatives or replacements for the current Cepheid GeneXpert systems, which are nearing the end of their lifecycle. The USCG currently operates 72 of these devices, with 52 under an active maintenance service plan that expires on September 29, 2025. The agency is looking for contractors who can provide FDA-approved molecular disease analyzers capable of performing various tests, including SARS-CoV-2, Influenza A, Influenza B, and women's health tests. Interested businesses should have experience in medical laboratory equipment and maintenance services, particularly in point-of-care testing environments.
Description

Title: Request for Information (RFI-2) for Device and Maintenance Services for Medical Point-of-Care Molecular Disease Analyzer

Agency: United States Coast Guard (USCG)

Date of Issuance: 16 May 2025


Entities
HSDO
Department of Homeland Security
UCG
U.S. Coast Guard
NAICS
621511
Set Aside
None
Place of Performance
Washington , District of Columbia 20593
Point of Contact
Full Name Email Phone Type
Jamison Harned [email protected] 5716135151 primary
Attachments
  • RFI2_20250516.docx